ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Ophthalmic Drug Delivery Device Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-33I9776
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Ophthalmic Drug Delivery Device Market Research Report 2022
BUY CHAPTERS

Global Ophthalmic Drug Delivery Device Market Research Report 2025

Code: QYRE-Auto-33I9776
Report
March 2025
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Aero Pump GmbH
AptarGroup
Bausch Health
Becton Dickinson& Company
Gaplast GmbH
Gerresheimer
Nemera
Nipro Corporation
Ocular Therapeutix
Owen Mumford
Silgan Holdings Inc.
Terumo Corporation
West Pharmaceutical Services, Inc.
EyePoint Pharmaceuticals, Inc.
Kedalion Therapeutics
Re-Vana Therapeutics
Mati Therapeutics, Inc.,
Biocorp Production
Ocumedic, Inc.

Ophthalmic Drug Delivery Device Market Size

The global market for Ophthalmic Drug Delivery Device was valued at US$ 178 million in the year 2024 and is projected to reach a revised size of US$ 238 million by 2031, growing at a CAGR of 4.3% during the forecast period.

Ophthalmic Drug Delivery Device Market

Ophthalmic Drug Delivery Device Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Ophthalmic Drug Delivery Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmic Drug Delivery Device.
The Ophthalmic Drug Delivery Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ophthalmic Drug Delivery Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ophthalmic Drug Delivery Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Ophthalmic Drug Delivery Device Market Report

Report Metric Details
Report Name Ophthalmic Drug Delivery Device Market
Accounted market size in year US$ 178 million
Forecasted market size in 2031 US$ 238 million
CAGR 4.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospitals
  • Clinics
  • Homecare
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Aero Pump GmbH, AptarGroup, Bausch Health, Becton Dickinson & Company, EyePoint Pharmaceuticals, Inc., Gaplast GmbH, Gerresheimer, Nemera, Nipro Corporation, Ocular Therapeutix, Owen Mumford, Silgan Holdings Inc., Terumo Corporation, West Pharmaceutical Services, Inc., Kedalion Therapeutics, Re-Vana Therapeutics, Mati Therapeutics, Inc.,, Biocorp Production, Ocumedic, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Ophthalmic Drug Delivery Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Ophthalmic Drug Delivery Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Ophthalmic Drug Delivery Device Market growing?

Ans: The Ophthalmic Drug Delivery Device Market witnessing a CAGR of 4.3% during the forecast period 2025-2031.

What is the Ophthalmic Drug Delivery Device Market size in 2031?

Ans: The Ophthalmic Drug Delivery Device Market size in 2031 will be US$ 238 million.

Who are the main players in the Ophthalmic Drug Delivery Device Market report?

Ans: The main players in the Ophthalmic Drug Delivery Device Market are Aero Pump GmbH, AptarGroup, Bausch Health, Becton Dickinson & Company, EyePoint Pharmaceuticals, Inc., Gaplast GmbH, Gerresheimer, Nemera, Nipro Corporation, Ocular Therapeutix, Owen Mumford, Silgan Holdings Inc., Terumo Corporation, West Pharmaceutical Services, Inc., Kedalion Therapeutics, Re-Vana Therapeutics, Mati Therapeutics, Inc.,, Biocorp Production, Ocumedic, Inc.

What are the Application segmentation covered in the Ophthalmic Drug Delivery Device Market report?

Ans: The Applications covered in the Ophthalmic Drug Delivery Device Market report are Hospitals, Clinics, Homecare, Others

What are the Type segmentation covered in the Ophthalmic Drug Delivery Device Market report?

Ans: The Types covered in the Ophthalmic Drug Delivery Device Market report are Pre-Filled Syringes, Multidose Eyedroppers, Squeeze Dispenser, Mist Sprayers, Add-On Devices, Contact Lenses, Others

Recommended Reports

Ophthalmic Devices

Drug Delivery

Ophthalmic Treatments

1 Ophthalmic Drug Delivery Device Market Overview
1.1 Product Definition
1.2 Ophthalmic Drug Delivery Device by Type
1.2.1 Global Ophthalmic Drug Delivery Device Market Value Comparison by Type (2024 VS 2031)
1.2.2 Pre-Filled Syringes
1.2.3 Multidose Eyedroppers
1.2.4 Squeeze Dispenser
1.2.5 Mist Sprayers
1.2.6 Add-On Devices
1.2.7 Contact Lenses
1.2.8 Others
1.3 Ophthalmic Drug Delivery Device by Application
1.3.1 Global Ophthalmic Drug Delivery Device Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Homecare
1.3.5 Others
1.4 Global Ophthalmic Drug Delivery Device Market Size Estimates and Forecasts
1.4.1 Global Ophthalmic Drug Delivery Device Revenue 2020-2031
1.4.2 Global Ophthalmic Drug Delivery Device Sales 2020-2031
1.4.3 Global Ophthalmic Drug Delivery Device Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Ophthalmic Drug Delivery Device Market Competition by Manufacturers
2.1 Global Ophthalmic Drug Delivery Device Sales Market Share by Manufacturers (2020-2025)
2.2 Global Ophthalmic Drug Delivery Device Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Ophthalmic Drug Delivery Device Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Ophthalmic Drug Delivery Device, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Ophthalmic Drug Delivery Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ophthalmic Drug Delivery Device, Product Type & Application
2.7 Global Key Manufacturers of Ophthalmic Drug Delivery Device, Date of Enter into This Industry
2.8 Global Ophthalmic Drug Delivery Device Market Competitive Situation and Trends
2.8.1 Global Ophthalmic Drug Delivery Device Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Ophthalmic Drug Delivery Device Players Market Share by Revenue
2.8.3 Global Ophthalmic Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Ophthalmic Drug Delivery Device Market Scenario by Region
3.1 Global Ophthalmic Drug Delivery Device Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Ophthalmic Drug Delivery Device Sales by Region: 2020-2031
3.2.1 Global Ophthalmic Drug Delivery Device Sales by Region: 2020-2025
3.2.2 Global Ophthalmic Drug Delivery Device Sales by Region: 2026-2031
3.3 Global Ophthalmic Drug Delivery Device Revenue by Region: 2020-2031
3.3.1 Global Ophthalmic Drug Delivery Device Revenue by Region: 2020-2025
3.3.2 Global Ophthalmic Drug Delivery Device Revenue by Region: 2026-2031
3.4 North America Ophthalmic Drug Delivery Device Market Facts & Figures by Country
3.4.1 North America Ophthalmic Drug Delivery Device Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Ophthalmic Drug Delivery Device Sales by Country (2020-2031)
3.4.3 North America Ophthalmic Drug Delivery Device Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Ophthalmic Drug Delivery Device Market Facts & Figures by Country
3.5.1 Europe Ophthalmic Drug Delivery Device Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Ophthalmic Drug Delivery Device Sales by Country (2020-2031)
3.5.3 Europe Ophthalmic Drug Delivery Device Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ophthalmic Drug Delivery Device Market Facts & Figures by Region
3.6.1 Asia Pacific Ophthalmic Drug Delivery Device Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Ophthalmic Drug Delivery Device Sales by Region (2020-2031)
3.6.3 Asia Pacific Ophthalmic Drug Delivery Device Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Ophthalmic Drug Delivery Device Market Facts & Figures by Country
3.7.1 Latin America Ophthalmic Drug Delivery Device Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Ophthalmic Drug Delivery Device Sales by Country (2020-2031)
3.7.3 Latin America Ophthalmic Drug Delivery Device Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ophthalmic Drug Delivery Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Ophthalmic Drug Delivery Device Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Ophthalmic Drug Delivery Device Sales by Country (2020-2031)
3.8.3 Middle East and Africa Ophthalmic Drug Delivery Device Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Ophthalmic Drug Delivery Device Sales by Type (2020-2031)
4.1.1 Global Ophthalmic Drug Delivery Device Sales by Type (2020-2025)
4.1.2 Global Ophthalmic Drug Delivery Device Sales by Type (2026-2031)
4.1.3 Global Ophthalmic Drug Delivery Device Sales Market Share by Type (2020-2031)
4.2 Global Ophthalmic Drug Delivery Device Revenue by Type (2020-2031)
4.2.1 Global Ophthalmic Drug Delivery Device Revenue by Type (2020-2025)
4.2.2 Global Ophthalmic Drug Delivery Device Revenue by Type (2026-2031)
4.2.3 Global Ophthalmic Drug Delivery Device Revenue Market Share by Type (2020-2031)
4.3 Global Ophthalmic Drug Delivery Device Price by Type (2020-2031)
5 Segment by Application
5.1 Global Ophthalmic Drug Delivery Device Sales by Application (2020-2031)
5.1.1 Global Ophthalmic Drug Delivery Device Sales by Application (2020-2025)
5.1.2 Global Ophthalmic Drug Delivery Device Sales by Application (2026-2031)
5.1.3 Global Ophthalmic Drug Delivery Device Sales Market Share by Application (2020-2031)
5.2 Global Ophthalmic Drug Delivery Device Revenue by Application (2020-2031)
5.2.1 Global Ophthalmic Drug Delivery Device Revenue by Application (2020-2025)
5.2.2 Global Ophthalmic Drug Delivery Device Revenue by Application (2026-2031)
5.2.3 Global Ophthalmic Drug Delivery Device Revenue Market Share by Application (2020-2031)
5.3 Global Ophthalmic Drug Delivery Device Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Aero Pump GmbH
6.1.1 Aero Pump GmbH Company Information
6.1.2 Aero Pump GmbH Description and Business Overview
6.1.3 Aero Pump GmbH Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Aero Pump GmbH Ophthalmic Drug Delivery Device Product Portfolio
6.1.5 Aero Pump GmbH Recent Developments/Updates
6.2 AptarGroup
6.2.1 AptarGroup Company Information
6.2.2 AptarGroup Description and Business Overview
6.2.3 AptarGroup Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AptarGroup Ophthalmic Drug Delivery Device Product Portfolio
6.2.5 AptarGroup Recent Developments/Updates
6.3 Bausch Health
6.3.1 Bausch Health Company Information
6.3.2 Bausch Health Description and Business Overview
6.3.3 Bausch Health Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bausch Health Ophthalmic Drug Delivery Device Product Portfolio
6.3.5 Bausch Health Recent Developments/Updates
6.4 Becton Dickinson & Company
6.4.1 Becton Dickinson & Company Company Information
6.4.2 Becton Dickinson & Company Description and Business Overview
6.4.3 Becton Dickinson & Company Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Becton Dickinson & Company Ophthalmic Drug Delivery Device Product Portfolio
6.4.5 Becton Dickinson & Company Recent Developments/Updates
6.5 EyePoint Pharmaceuticals, Inc.
6.5.1 EyePoint Pharmaceuticals, Inc. Company Information
6.5.2 EyePoint Pharmaceuticals, Inc. Description and Business Overview
6.5.3 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.5.4 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Product Portfolio
6.5.5 EyePoint Pharmaceuticals, Inc. Recent Developments/Updates
6.6 Gaplast GmbH
6.6.1 Gaplast GmbH Company Information
6.6.2 Gaplast GmbH Description and Business Overview
6.6.3 Gaplast GmbH Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Gaplast GmbH Ophthalmic Drug Delivery Device Product Portfolio
6.6.5 Gaplast GmbH Recent Developments/Updates
6.7 Gerresheimer
6.7.1 Gerresheimer Company Information
6.7.2 Gerresheimer Description and Business Overview
6.7.3 Gerresheimer Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Gerresheimer Ophthalmic Drug Delivery Device Product Portfolio
6.7.5 Gerresheimer Recent Developments/Updates
6.8 Nemera
6.8.1 Nemera Company Information
6.8.2 Nemera Description and Business Overview
6.8.3 Nemera Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Nemera Ophthalmic Drug Delivery Device Product Portfolio
6.8.5 Nemera Recent Developments/Updates
6.9 Nipro Corporation
6.9.1 Nipro Corporation Company Information
6.9.2 Nipro Corporation Description and Business Overview
6.9.3 Nipro Corporation Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Nipro Corporation Ophthalmic Drug Delivery Device Product Portfolio
6.9.5 Nipro Corporation Recent Developments/Updates
6.10 Ocular Therapeutix
6.10.1 Ocular Therapeutix Company Information
6.10.2 Ocular Therapeutix Description and Business Overview
6.10.3 Ocular Therapeutix Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Ocular Therapeutix Ophthalmic Drug Delivery Device Product Portfolio
6.10.5 Ocular Therapeutix Recent Developments/Updates
6.11 Owen Mumford
6.11.1 Owen Mumford Company Information
6.11.2 Owen Mumford Description and Business Overview
6.11.3 Owen Mumford Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Owen Mumford Ophthalmic Drug Delivery Device Product Portfolio
6.11.5 Owen Mumford Recent Developments/Updates
6.12 Silgan Holdings Inc.
6.12.1 Silgan Holdings Inc. Company Information
6.12.2 Silgan Holdings Inc. Description and Business Overview
6.12.3 Silgan Holdings Inc. Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Silgan Holdings Inc. Ophthalmic Drug Delivery Device Product Portfolio
6.12.5 Silgan Holdings Inc. Recent Developments/Updates
6.13 Terumo Corporation
6.13.1 Terumo Corporation Company Information
6.13.2 Terumo Corporation Description and Business Overview
6.13.3 Terumo Corporation Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Terumo Corporation Ophthalmic Drug Delivery Device Product Portfolio
6.13.5 Terumo Corporation Recent Developments/Updates
6.14 West Pharmaceutical Services, Inc.
6.14.1 West Pharmaceutical Services, Inc. Company Information
6.14.2 West Pharmaceutical Services, Inc. Description and Business Overview
6.14.3 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.14.4 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Product Portfolio
6.14.5 West Pharmaceutical Services, Inc. Recent Developments/Updates
6.15 Kedalion Therapeutics
6.15.1 Kedalion Therapeutics Company Information
6.15.2 Kedalion Therapeutics Description and Business Overview
6.15.3 Kedalion Therapeutics Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Kedalion Therapeutics Ophthalmic Drug Delivery Device Product Portfolio
6.15.5 Kedalion Therapeutics Recent Developments/Updates
6.16 Re-Vana Therapeutics
6.16.1 Re-Vana Therapeutics Company Information
6.16.2 Re-Vana Therapeutics Description and Business Overview
6.16.3 Re-Vana Therapeutics Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Re-Vana Therapeutics Ophthalmic Drug Delivery Device Product Portfolio
6.16.5 Re-Vana Therapeutics Recent Developments/Updates
6.17 Mati Therapeutics, Inc.,
6.17.1 Mati Therapeutics, Inc., Company Information
6.17.2 Mati Therapeutics, Inc., Description and Business Overview
6.17.3 Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Product Portfolio
6.17.5 Mati Therapeutics, Inc., Recent Developments/Updates
6.18 Biocorp Production
6.18.1 Biocorp Production Company Information
6.18.2 Biocorp Production Description and Business Overview
6.18.3 Biocorp Production Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Biocorp Production Ophthalmic Drug Delivery Device Product Portfolio
6.18.5 Biocorp Production Recent Developments/Updates
6.19 Ocumedic, Inc.
6.19.1 Ocumedic, Inc. Company Information
6.19.2 Ocumedic, Inc. Description and Business Overview
6.19.3 Ocumedic, Inc. Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Ocumedic, Inc. Ophthalmic Drug Delivery Device Product Portfolio
6.19.5 Ocumedic, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ophthalmic Drug Delivery Device Industry Chain Analysis
7.2 Ophthalmic Drug Delivery Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ophthalmic Drug Delivery Device Production Mode & Process Analysis
7.4 Ophthalmic Drug Delivery Device Sales and Marketing
7.4.1 Ophthalmic Drug Delivery Device Sales Channels
7.4.2 Ophthalmic Drug Delivery Device Distributors
7.5 Ophthalmic Drug Delivery Device Customer Analysis
8 Ophthalmic Drug Delivery Device Market Dynamics
8.1 Ophthalmic Drug Delivery Device Industry Trends
8.2 Ophthalmic Drug Delivery Device Market Drivers
8.3 Ophthalmic Drug Delivery Device Market Challenges
8.4 Ophthalmic Drug Delivery Device Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Aero Pump GmbH
AptarGroup
Bausch Health
Becton Dickinson& Company
Gaplast GmbH
Gerresheimer
Nemera
Nipro Corporation
Ocular Therapeutix
Owen Mumford
Silgan Holdings Inc.
Terumo Corporation
West Pharmaceutical Services, Inc.
EyePoint Pharmaceuticals, Inc.
Kedalion Therapeutics
Re-Vana Therapeutics
Mati Therapeutics, Inc.,
Biocorp Production
Ocumedic, Inc.
List of Tables
 Table 1. Global Ophthalmic Drug Delivery Device Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Ophthalmic Drug Delivery Device Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Ophthalmic Drug Delivery Device Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Ophthalmic Drug Delivery Device Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Ophthalmic Drug Delivery Device Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Ophthalmic Drug Delivery Device Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Ophthalmic Drug Delivery Device Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Ophthalmic Drug Delivery Device Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Ophthalmic Drug Delivery Device, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Ophthalmic Drug Delivery Device, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Ophthalmic Drug Delivery Device, Product Type & Application
 Table 12. Global Key Manufacturers of Ophthalmic Drug Delivery Device, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Ophthalmic Drug Delivery Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Drug Delivery Device as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Ophthalmic Drug Delivery Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Ophthalmic Drug Delivery Device Sales by Region (2020-2025) & (K Units)
 Table 18. Global Ophthalmic Drug Delivery Device Sales Market Share by Region (2020-2025)
 Table 19. Global Ophthalmic Drug Delivery Device Sales by Region (2026-2031) & (K Units)
 Table 20. Global Ophthalmic Drug Delivery Device Sales Market Share by Region (2026-2031)
 Table 21. Global Ophthalmic Drug Delivery Device Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Ophthalmic Drug Delivery Device Revenue Market Share by Region (2020-2025)
 Table 23. Global Ophthalmic Drug Delivery Device Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Ophthalmic Drug Delivery Device Revenue Market Share by Region (2026-2031)
 Table 25. North America Ophthalmic Drug Delivery Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Ophthalmic Drug Delivery Device Sales by Country (2020-2025) & (K Units)
 Table 27. North America Ophthalmic Drug Delivery Device Sales by Country (2026-2031) & (K Units)
 Table 28. North America Ophthalmic Drug Delivery Device Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Ophthalmic Drug Delivery Device Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Ophthalmic Drug Delivery Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Ophthalmic Drug Delivery Device Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Ophthalmic Drug Delivery Device Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Ophthalmic Drug Delivery Device Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Ophthalmic Drug Delivery Device Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Ophthalmic Drug Delivery Device Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Ophthalmic Drug Delivery Device Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Ophthalmic Drug Delivery Device Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Ophthalmic Drug Delivery Device Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Ophthalmic Drug Delivery Device Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Ophthalmic Drug Delivery Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Ophthalmic Drug Delivery Device Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Ophthalmic Drug Delivery Device Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Ophthalmic Drug Delivery Device Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Ophthalmic Drug Delivery Device Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Ophthalmic Drug Delivery Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Ophthalmic Drug Delivery Device Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Ophthalmic Drug Delivery Device Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Ophthalmic Drug Delivery Device Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Ophthalmic Drug Delivery Device Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Ophthalmic Drug Delivery Device Sales (K Units) by Type (2020-2025)
 Table 51. Global Ophthalmic Drug Delivery Device Sales (K Units) by Type (2026-2031)
 Table 52. Global Ophthalmic Drug Delivery Device Sales Market Share by Type (2020-2025)
 Table 53. Global Ophthalmic Drug Delivery Device Sales Market Share by Type (2026-2031)
 Table 54. Global Ophthalmic Drug Delivery Device Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Ophthalmic Drug Delivery Device Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Ophthalmic Drug Delivery Device Revenue Market Share by Type (2020-2025)
 Table 57. Global Ophthalmic Drug Delivery Device Revenue Market Share by Type (2026-2031)
 Table 58. Global Ophthalmic Drug Delivery Device Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Ophthalmic Drug Delivery Device Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Ophthalmic Drug Delivery Device Sales (K Units) by Application (2020-2025)
 Table 61. Global Ophthalmic Drug Delivery Device Sales (K Units) by Application (2026-2031)
 Table 62. Global Ophthalmic Drug Delivery Device Sales Market Share by Application (2020-2025)
 Table 63. Global Ophthalmic Drug Delivery Device Sales Market Share by Application (2026-2031)
 Table 64. Global Ophthalmic Drug Delivery Device Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Ophthalmic Drug Delivery Device Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Ophthalmic Drug Delivery Device Revenue Market Share by Application (2020-2025)
 Table 67. Global Ophthalmic Drug Delivery Device Revenue Market Share by Application (2026-2031)
 Table 68. Global Ophthalmic Drug Delivery Device Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Ophthalmic Drug Delivery Device Price (US$/Unit) by Application (2026-2031)
 Table 70. Aero Pump GmbH Company Information
 Table 71. Aero Pump GmbH Description and Business Overview
 Table 72. Aero Pump GmbH Ophthalmic Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Aero Pump GmbH Ophthalmic Drug Delivery Device Product
 Table 74. Aero Pump GmbH Recent Developments/Updates
 Table 75. AptarGroup Company Information
 Table 76. AptarGroup Description and Business Overview
 Table 77. AptarGroup Ophthalmic Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. AptarGroup Ophthalmic Drug Delivery Device Product
 Table 79. AptarGroup Recent Developments/Updates
 Table 80. Bausch Health Company Information
 Table 81. Bausch Health Description and Business Overview
 Table 82. Bausch Health Ophthalmic Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Bausch Health Ophthalmic Drug Delivery Device Product
 Table 84. Bausch Health Recent Developments/Updates
 Table 85. Becton Dickinson & Company Company Information
 Table 86. Becton Dickinson & Company Description and Business Overview
 Table 87. Becton Dickinson & Company Ophthalmic Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Becton Dickinson & Company Ophthalmic Drug Delivery Device Product
 Table 89. Becton Dickinson & Company Recent Developments/Updates
 Table 90. EyePoint Pharmaceuticals, Inc. Company Information
 Table 91. EyePoint Pharmaceuticals, Inc. Description and Business Overview
 Table 92. EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Product
 Table 94. EyePoint Pharmaceuticals, Inc. Recent Developments/Updates
 Table 95. Gaplast GmbH Company Information
 Table 96. Gaplast GmbH Description and Business Overview
 Table 97. Gaplast GmbH Ophthalmic Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Gaplast GmbH Ophthalmic Drug Delivery Device Product
 Table 99. Gaplast GmbH Recent Developments/Updates
 Table 100. Gerresheimer Company Information
 Table 101. Gerresheimer Description and Business Overview
 Table 102. Gerresheimer Ophthalmic Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Gerresheimer Ophthalmic Drug Delivery Device Product
 Table 104. Gerresheimer Recent Developments/Updates
 Table 105. Nemera Company Information
 Table 106. Nemera Description and Business Overview
 Table 107. Nemera Ophthalmic Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Nemera Ophthalmic Drug Delivery Device Product
 Table 109. Nemera Recent Developments/Updates
 Table 110. Nipro Corporation Company Information
 Table 111. Nipro Corporation Description and Business Overview
 Table 112. Nipro Corporation Ophthalmic Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Nipro Corporation Ophthalmic Drug Delivery Device Product
 Table 114. Nipro Corporation Recent Developments/Updates
 Table 115. Ocular Therapeutix Company Information
 Table 116. Ocular Therapeutix Description and Business Overview
 Table 117. Ocular Therapeutix Ophthalmic Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Ocular Therapeutix Ophthalmic Drug Delivery Device Product
 Table 119. Ocular Therapeutix Recent Developments/Updates
 Table 120. Owen Mumford Company Information
 Table 121. Owen Mumford Description and Business Overview
 Table 122. Owen Mumford Ophthalmic Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Owen Mumford Ophthalmic Drug Delivery Device Product
 Table 124. Owen Mumford Recent Developments/Updates
 Table 125. Silgan Holdings Inc. Company Information
 Table 126. Silgan Holdings Inc. Description and Business Overview
 Table 127. Silgan Holdings Inc. Ophthalmic Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Silgan Holdings Inc. Ophthalmic Drug Delivery Device Product
 Table 129. Silgan Holdings Inc. Recent Developments/Updates
 Table 130. Terumo Corporation Company Information
 Table 131. Terumo Corporation Description and Business Overview
 Table 132. Terumo Corporation Ophthalmic Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Terumo Corporation Ophthalmic Drug Delivery Device Product
 Table 134. Terumo Corporation Recent Developments/Updates
 Table 135. West Pharmaceutical Services, Inc. Company Information
 Table 136. West Pharmaceutical Services, Inc. Description and Business Overview
 Table 137. West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Product
 Table 139. West Pharmaceutical Services, Inc. Recent Developments/Updates
 Table 140. Kedalion Therapeutics Company Information
 Table 141. Kedalion Therapeutics Description and Business Overview
 Table 142. Kedalion Therapeutics Ophthalmic Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Kedalion Therapeutics Ophthalmic Drug Delivery Device Product
 Table 144. Kedalion Therapeutics Recent Developments/Updates
 Table 145. Re-Vana Therapeutics Company Information
 Table 146. Re-Vana Therapeutics Description and Business Overview
 Table 147. Re-Vana Therapeutics Ophthalmic Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Re-Vana Therapeutics Ophthalmic Drug Delivery Device Product
 Table 149. Re-Vana Therapeutics Recent Developments/Updates
 Table 150. Mati Therapeutics, Inc., Company Information
 Table 151. Mati Therapeutics, Inc., Description and Business Overview
 Table 152. Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Product
 Table 154. Mati Therapeutics, Inc., Recent Developments/Updates
 Table 155. Biocorp Production Company Information
 Table 156. Biocorp Production Description and Business Overview
 Table 157. Biocorp Production Ophthalmic Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Biocorp Production Ophthalmic Drug Delivery Device Product
 Table 159. Biocorp Production Recent Developments/Updates
 Table 160. Ocumedic, Inc. Company Information
 Table 161. Ocumedic, Inc. Description and Business Overview
 Table 162. Ocumedic, Inc. Ophthalmic Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Ocumedic, Inc. Ophthalmic Drug Delivery Device Product
 Table 164. Ocumedic, Inc. Recent Developments/Updates
 Table 165. Key Raw Materials Lists
 Table 166. Raw Materials Key Suppliers Lists
 Table 167. Ophthalmic Drug Delivery Device Distributors List
 Table 168. Ophthalmic Drug Delivery Device Customers List
 Table 169. Ophthalmic Drug Delivery Device Market Trends
 Table 170. Ophthalmic Drug Delivery Device Market Drivers
 Table 171. Ophthalmic Drug Delivery Device Market Challenges
 Table 172. Ophthalmic Drug Delivery Device Market Restraints
 Table 173. Research Programs/Design for This Report
 Table 174. Key Data Information from Secondary Sources
 Table 175. Key Data Information from Primary Sources
 Table 176. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Ophthalmic Drug Delivery Device
 Figure 2. Global Ophthalmic Drug Delivery Device Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Ophthalmic Drug Delivery Device Market Share by Type: 2024 & 2031
 Figure 4. Pre-Filled Syringes Product Picture
 Figure 5. Multidose Eyedroppers Product Picture
 Figure 6. Squeeze Dispenser Product Picture
 Figure 7. Mist Sprayers Product Picture
 Figure 8. Add-On Devices Product Picture
 Figure 9. Contact Lenses Product Picture
 Figure 10. Others Product Picture
 Figure 11. Global Ophthalmic Drug Delivery Device Market Value by Application (2020-2031) & (US$ Million)
 Figure 12. Global Ophthalmic Drug Delivery Device Market Share by Application: 2024 & 2031
 Figure 13. Hospitals
 Figure 14. Clinics
 Figure 15. Homecare
 Figure 16. Others
 Figure 17. Global Ophthalmic Drug Delivery Device Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Ophthalmic Drug Delivery Device Market Size (2020-2031) & (US$ Million)
 Figure 19. Global Ophthalmic Drug Delivery Device Sales (2020-2031) & (K Units)
 Figure 20. Global Ophthalmic Drug Delivery Device Average Price (US$/Unit) & (2020-2031)
 Figure 21. Ophthalmic Drug Delivery Device Report Years Considered
 Figure 22. Ophthalmic Drug Delivery Device Sales Share by Manufacturers in 2024
 Figure 23. Global Ophthalmic Drug Delivery Device Revenue Share by Manufacturers in 2024
 Figure 24. Global 5 and 10 Largest Ophthalmic Drug Delivery Device Players: Market Share by Revenue in Ophthalmic Drug Delivery Device in 2024
 Figure 25. Ophthalmic Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Global Ophthalmic Drug Delivery Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 27. North America Ophthalmic Drug Delivery Device Sales Market Share by Country (2020-2031)
 Figure 28. North America Ophthalmic Drug Delivery Device Revenue Market Share by Country (2020-2031)
 Figure 29. U.S. Ophthalmic Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Canada Ophthalmic Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Europe Ophthalmic Drug Delivery Device Sales Market Share by Country (2020-2031)
 Figure 32. Europe Ophthalmic Drug Delivery Device Revenue Market Share by Country (2020-2031)
 Figure 33. Germany Ophthalmic Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. France Ophthalmic Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. U.K. Ophthalmic Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Italy Ophthalmic Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Russia Ophthalmic Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Asia Pacific Ophthalmic Drug Delivery Device Sales Market Share by Region (2020-2031)
 Figure 39. Asia Pacific Ophthalmic Drug Delivery Device Revenue Market Share by Region (2020-2031)
 Figure 40. China Ophthalmic Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Japan Ophthalmic Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. South Korea Ophthalmic Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. India Ophthalmic Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Australia Ophthalmic Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Taiwan Ophthalmic Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Indonesia Ophthalmic Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Thailand Ophthalmic Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Malaysia Ophthalmic Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Philippines Ophthalmic Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Latin America Ophthalmic Drug Delivery Device Sales Market Share by Country (2020-2031)
 Figure 51. Latin America Ophthalmic Drug Delivery Device Revenue Market Share by Country (2020-2031)
 Figure 52. Mexico Ophthalmic Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Brazil Ophthalmic Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Argentina Ophthalmic Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Middle East and Africa Ophthalmic Drug Delivery Device Sales Market Share by Country (2020-2031)
 Figure 56. Middle East and Africa Ophthalmic Drug Delivery Device Revenue Market Share by Country (2020-2031)
 Figure 57. Turkey Ophthalmic Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Saudi Arabia Ophthalmic Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. U.A.E Ophthalmic Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 60. Global Sales Market Share of Ophthalmic Drug Delivery Device by Type (2020-2031)
 Figure 61. Global Revenue Market Share of Ophthalmic Drug Delivery Device by Type (2020-2031)
 Figure 62. Global Ophthalmic Drug Delivery Device Price (US$/Unit) by Type (2020-2031)
 Figure 63. Global Sales Market Share of Ophthalmic Drug Delivery Device by Application (2020-2031)
 Figure 64. Global Revenue Market Share of Ophthalmic Drug Delivery Device by Application (2020-2031)
 Figure 65. Global Ophthalmic Drug Delivery Device Price (US$/Unit) by Application (2020-2031)
 Figure 66. Ophthalmic Drug Delivery Device Value Chain
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Ophthalmology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ophthalmic Drug Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ocular Drug Delivery Market Research Report 2025
Ophthalmic Pharmaceutical Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ophthalmic Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ocular Drug Delivery Devices Market Research Report 2025
Drug Delivery Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharma Ophthalmic Market Research Report 2025
Vaccine Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccines Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ophthalmic Anti Infective Drugs Market Research Report 2025
Pulmonary Drug Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ophthalmology AI assisted Diagnosis Software Market Research Report 2024
Ophthalmic Disease Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Common Drugs Use in Ophthalmology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Desktop Ophthalmic Ultrasound Diagnostic Instrument Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Eye Drug Market Insights Forecast to 2030
Nanotechnology Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Injectable Drug Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ophthalmic Ultrasound Diagnostic Instrument Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions